Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 308

    1.

    The heartbreak of drug pricing.

    Davidoff F.

    Ann Intern Med. 2001 Jun 5;134(11):1068-71. No abstract available. PMID: 11388821 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Prescription drug pricing: the consumer perspective.

    Searing A.

    N C Med J. 2003 Nov-Dec;64(6):300-2. No abstract available. PMID: 14983625 [PubMed - indexed for MEDLINE]Related articles

    3.

    An absolute waste.

    Haley D.

    Hosp Health Netw. 2002 May;76(5):12. No abstract available. PMID: 12035561 [PubMed - indexed for MEDLINE]Related articles

    4.

    Patent nonsense: evidence tells of an industry out of social control.

    Mintzberg H.

    CMAJ. 2006 Aug 15;175(4):374. No abstract available. PMID: 16908900 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The heartbreak of drug pricing.

    Ross JS.

    Ann Intern Med. 2002 Jun 4;136(11):853-4; author reply 853-4. No abstract available. PMID: 12044138 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The latest trends in the pharmaceutical market.

    Teitelbaum F.

    Case Manager. 2000 Sep-Oct;11(5):70-4. No abstract available. PMID: 11935588 [PubMed - indexed for MEDLINE]Related articles

    7.

    The pharmaceutical industry--prices and progress.

    Scherer FM.

    N Engl J Med. 2004 Aug 26;351(9):927-32. No abstract available. PMID: 15329432 [PubMed - indexed for MEDLINE]Related articles

    8.

    The rising utilization and costs of prescription drugs.

    [No authors listed]

    PHC4 FYI. 2004;(26):1-2. No abstract available. PMID: 15344277 [PubMed - indexed for MEDLINE]Related articles

    9.

    The pharmaceutical industry--to whom is it accountable?

    Holmer AF.

    N Engl J Med. 2000 Nov 9;343(19):1415; discussion 1417. No abstract available. PMID: 11183877 [PubMed - indexed for MEDLINE]Related articles

    10.

    High drug costs seem to keep getting higher.

    Ackerman W.

    J Ark Med Soc. 2005 Apr;101(10):293. No abstract available. PMID: 15839313 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prescription drug advertising: is it a driving force on drug pricing?

    Millstein LG.

    N C Med J. 2003 Nov-Dec;64(6):289-91.PMID: 14983621 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comment: the economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?

    Rosenthal M.

    J Health Serv Res Policy. 2004 Jan;9(1):39-42; discussion 41-2. No abstract available. PMID: 15006239 [PubMed - indexed for MEDLINE]Related articles

    13.

    Are prescription drug prices high?

    Vagelos PR.

    Science. 1991 May 24;252(5010):1080-4.PMID: 2031182 [PubMed - indexed for MEDLINE]Related articles

    14.

    Why drugs cost so much.

    Noonan D.

    Newsweek. 2000 Sep 25;136(13):22-30. No abstract available. PMID: 11183315 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prescription drug pushers. Patents and ads are the big reasons pills are priced like perfume and caviar.

    Sherrid P.

    US News World Rep. 2000 Oct 30;129(17):40-2. No abstract available. PMID: 11184929 [PubMed - indexed for MEDLINE]Related articles

    16.

    The pharmaceutical industry--to whom is it accountable?

    Jacobs C.

    N Engl J Med. 2000 Nov 9;343(19):1416-7; discussion 1417. No abstract available. PMID: 11183878 [PubMed - indexed for MEDLINE]Related articles

    17.

    Matching prescription drugs and consumers. The benefits of direct advertising.

    Masson A, Rubin PH.

    N Engl J Med. 1985 Aug 22;313(8):513-5. No abstract available. PMID: 4022085 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Observations on economizing on drug costs]

    Offerhaus L.

    Ned Tijdschr Geneeskd. 1982 May 1;126(18):824-9. Dutch. No abstract available. PMID: 7088209 [PubMed - indexed for MEDLINE]Related articles

    19.

    The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace.

    Sollano JA, Kirsch JM, Bala MV, Chambers MG, Harpole LH.

    Clin Pharmacol Ther. 2008 Aug;84(2):263-6. Epub 2008 Jun 11.PMID: 18547999 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data